BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.38
-0.07 (-0.83%)
Aug 15, 2025, 10:52 AM - Market open
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 580 employees as of December 31, 2024. The number of employees increased by 44 or 8.21% compared to the previous year.
Employees
580
Change (1Y)
44
Growth (1Y)
8.21%
Revenue / Employee
$961,217
Profits / Employee
-$61,571
Market Cap
1.76B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 580 | 44 | 8.21% |
Dec 31, 2023 | 536 | 5 | 0.94% |
Dec 31, 2022 | 531 | 173 | 48.32% |
Dec 31, 2021 | 358 | 112 | 45.53% |
Dec 31, 2020 | 246 | 106 | 75.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BCRX News
- 4 days ago - BioCryst Announces Departure of Dr. Helen Thackray - GlobeNewsWire
- 9 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - BioCryst Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 15 days ago - BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December - GlobeNewsWire
- 25 days ago - BioCryst to Report Second Quarter 2025 Financial Results on August 4 - GlobeNewsWire
- 5 weeks ago - BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit - GlobeNewsWire
- 5 weeks ago - BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development - GlobeNewsWire